Chapter 117. The Health Economics of Asthma

  1. William W. Busse MD1 and
  2. Stephen T. Holgate BSc, MD, FRCP2
  1. Kevin B. Weiss and
  2. Sean D. Sullivan

Published Online: 16 APR 2008

DOI: 10.1002/9780470694923.ch47

Asthma and Rhinitis, Second Edition

Asthma and Rhinitis, Second Edition

How to Cite

Weiss, K. B. and Sullivan, S. D. (2000) The Health Economics of Asthma, in Asthma and Rhinitis, Second Edition (eds W. W. Busse and S. T. Holgate), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470694923.ch47

Editor Information

  1. 1

    Professor of Medicine Head, Clinical Immunology, University of Wisconsin-Madison Medical School, Department of Medicine, Madison Wisconsin, USA

  2. 2

    Clinical Professor of Immuno-Pharmacology, Medical Specialties, Southampton General Hospital, Youthampton, UK

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2000

ISBN Information

Print ISBN: 9780632041756

Online ISBN: 9780470694923



  • asthma;
  • health-care services;
  • inhaled budesonide;
  • corticosteroids;
  • long-acting bronchodilators


This chapter contains section titled:

  • Introduction

  • Cost-of-Illness Studies of Asthma

  • Comparative Health Economic Studies and the Basics of Cost-Effectiveness Analysis

  • Asthma-Related Health Economic Studies

  • Setting Standards for Health Economic Evaluations of Asthma Care

  • Using Cost-Effectiveness Analysis to Inform Clinical Care for Asthma

  • Conclusion

  • References